EMEA committee recommendations for paroxetine and other SSRIs

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1032, 2004-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EMEA concludes SSRIs and SNRIs not for use in children, adolescents

By  

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

SSRIs versus Non-SSRIs in Post-traumatic Stress Disorder: An Update with Recommendations

By Asnis G.M.   Kohn S.R.   Henderson M.   Brown N.L.  

Drugs, Vol. 64, Iss. 4, 2004-01 ,pp. : 383-404

Adis International

Access to resources Recommend Favorite

Paroxetine: Migraine and other toxicities: 8 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1420, 2012-01 ,pp. : 40-40

Adis International

Access to resources Recommend Favorite

Ontario's Formulary Committee: How Recommendations Are Made

By PausJenssen A.M.  

PharmacoEconomics, Vol. 21, Iss. 4, 2003-01 ,pp. : 285-294

Adis International

Access to resources Recommend Favorite

Chronic Paroxetine Treatment: Effects on Other Non-Serotonergic Neurotransmitter Systems

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1226-1232

Bentham Science Publishers

Access to resources Recommend Favorite